Main navigation

Vol 34, (8):610 - 704

Breast cancer - New and emerging technologies for diagnosis and management

Nehmat Houssami, MBBS, FAFPHM, FASBP, PhD, is Associate Clinical Director, NSW Breast Cancer Institute, Westmead Hospital, and Honorary Senior Lecturer, Screening and Test Evaluation Program, School of Public Health, University of Sydney, New South Wales.

James French, MBBS, FRACS, is a breast and endocrine surgeon, NSW Breast Cancer Institute, Westmead Hospital, New South Wales.

Meagan Brennan, BMed, FRACGP, DFM, FASBP, is a breast physician, NSW Breast Cancer Institute, Westmead Hospital, New South Wales.

Verity Ahern, MBBS, FRANZCR, is a radiation oncologist, NSW Breast Cancer Institute, Westmead Hospital, and Senior Lecturer, University of Sydney, New South Wales.Owen Ung, MBBS, FRACS, is a breast and endocrine surgeon, NSW Breast Cancer Institute, Westmead Hospital, and Associate Clinical Professor, University of Sydney, New South Wales.

Part six of this series discusses established and emerging technologies in breast cancer care, with an emphasis on technologies in diagnosis and treatment supported by evidence. These include percutaneous core biopsy techniques and breast imaging in diagnosis. From the surgical perspective, we discuss the emerging role of sentinel node biopsy as a potentially less invasive method of staging the axilla in women with breast cancer. We also review advances in radiotherapy techniques that have allowed delivery of radiotherapy with more precision and improved safety.

Publication Date: 26 July 2005
Authorised By: Australian Family Physician